This Offering Will Not Dilute Quantum BioPharma ShareholdersTORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a ...

Quantum explicitly framed the investment as part of its ongoing fight against market corruption and manipulative trading.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) , a biopharmaceutical company focused on building innovative biotech assets, announced that portfolio co ...

GameStop (GME) shares face a tough streak, down 28% YTD. Discover insights into strategic investments, valuation challenges, ...

Investing.com -- Quantum BioPharma Ltd. (NASDAQ: QNTM) stock fell 5.7% after the company announced it purchased 2,000 shares ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to innovative therapies for ...

Quantum BioPharma (NASDAQ: QNTM) , a biopharmaceutical company focused on neurodegenerative therapies, has purchased 2,000 shares of GameStop Corp. ( ...

Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.

Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.

Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.

Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.